Age-adjusted D-dimer cutoff for the diagnosis of pulmonary embolism: A cost-effectiveness analysis.
Marc BlondonGrégoire Le GalGuy MeyerMarc RighiniHelia Robert-EbadiPublished in: Journal of thrombosis and haemostasis : JTH (2020)
The AADD cutoff results in a clinically nonsignificant decrease in QALY but important costs reductions. It is a decrementally cost-effective innovation, with a potential of cost savings of >$80 million per year for the United States health care system.